Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
116076 trials found · Page 588 of 5804
-
Freezing heart tissue to stop lethal rhythms: new trial launches
Disease control Recruiting nowThe objective of this clinical study is to evaluate the safety and effectiveness of the Adagio VT Cryoablation System in the ablation treatment of Sustained Monomorphic Ventricular Tachycardia (SMVT)
Phase: NA • Sponsor: Adagio Medical • Aim: Disease control
Last updated Jun 27, 2026 12:04 UTC
-
New pill could tame Sjögren's syndrome
Disease control OngoingThe purpose of this study is to assess the safety and efficacy of two doses of Deucravacitinib in adult participants with Active Sjögren's Syndrome.
Phase: PHASE3 • Sponsor: Bristol-Myers Squibb • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC
-
Could a plasma protein cut deaths in severe pneumonia?
Disease control Recruiting nowThe main objective of the trial is to assess the efficacy and safety of trimodulin as adjunctive treatment to standard of care (SoC) compared to placebo plus SoC in hospitalized subjects with sCAP on invasive mechanical ventilation (IMV). Other objectives are to determine detail…
Phase: PHASE3 • Sponsor: Biotest • Aim: Disease control
Last updated Jul 26, 2026 00:00 UTC
-
Gene therapy shot could end frequent eye injections for wet AMD
Disease control OngoingThis study will evaluate the safety, tolerability, and preliminary efficacy of NG101 AAV gene therapy administered by subretinal injections into a single selected eye as a single selected dose for patients with wet age-related macular degeneration (wAMD).
Phase: PHASE1, PHASE2 • Sponsor: Elisigen, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:13 UTC
-
New hope for advanced breast cancer: drug combo targets resistant tumors
Disease control Recruiting nowThis study evaluated the safety and efficacy of SPH4336 in combination with endocrine therapy in the treatment of locally advanced or metastatic breast cancer that progressed on CDK4/6 inhibitor combined with endocrine therapy.
Phase: PHASE2, PHASE3 • Sponsor: Shanghai Pharmaceuticals Holding Co., Ltd • Aim: Disease control
Last updated Jun 27, 2026 08:11 UTC
-
Engineered immune cells take aim at rare bone and soft tissue cancers
Disease control Recruiting nowTo find a recommended dose of attIL2-T cell therapy that can be given to patients with soft tissue or bone sarcomas and to see if it can help to control the disease.
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
Could a ZAP of radiation before standard care beat back metastatic kidney cancer?
Disease control OngoingThis phase III trial compares the effect of stero-ablative radiotherapy (SAbR) followed by standard of care systemic therapy, to standard of care systemic therapy alone, in patients with kidney cancer that has spread from where it first started (primary site) to a limited (2-5) n…
Phase: PHASE3 • Sponsor: ECOG-ACRIN Cancer Research Group • Aim: Disease control
Last updated Jul 19, 2026 00:00 UTC
-
Balloon or stent? major trial tests safer option for clogged heart arteries
Disease control OngoingProspective, randomised, open-label, international multicenter trial to evaluate the safety and efficacy of drug-coated balloon (DCB) treatment compared to drug-eluting stenting (DES) in patients with large coronary artery disease.
Phase: NA • Sponsor: B. Braun Medical Industries Sdn. Bhd. • Aim: Disease control
Last updated Jun 27, 2026 12:39 UTC
-
Lab-Made blood vessel could free dialysis patients from catheters
Disease control OngoingThe goal of this clinical trial is to compare the number of catheter-free days (CFD) and the rate and severity of any dialysis access-related infections between the ATEV and AVF groups over 12 months in patients with end-stage renal disease (ESRD) needing hemodialysis (HD). Part…
Phase: PHASE3 • Sponsor: Humacyte, Inc. • Aim: Disease control
Last updated Jun 28, 2026 00:00 UTC
-
Can a drug calm long COVID's lung inflammation? new trial aims to find out
Disease control Recruiting nowThe PRECISION is a proof-of-concept, phase II randomized clinical trial aiming to evaluate the efficacy and safety of anakinra in patients with Post-Acute COVID Syndrome (PACS) of the pro-inflammatory respiratory phenotype. Improvement is measured by a composite endpoint, namely,…
Phase: PHASE2, PHASE3 • Sponsor: Hellenic Institute for the Study of Sepsis • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New mRNA vaccine aims to tame genital herpes recurrences
Disease control CompletedThe purpose of this study is to generate safety and immunogenicity data and establish a proof-of-concept of clinical benefit of the mRNA-1608 vaccine candidate.
Phase: PHASE1, PHASE2 • Sponsor: ModernaTX, Inc. • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Can 'Zombie Cell' drugs strengthen aging bones?
Disease control OngoingThis randomised clinical trial aims to study osteoporosis as a disease of accelerated skeletal aging caused by the accumulation of senescent cells within the skeleton and investigate the effects and safety of senolytics and antioxidant therapy on bone.
Phase: PHASE2 • Sponsor: Odense University Hospital • Aim: Disease control
Last updated Jun 27, 2026 12:31 UTC
-
New drug combo aims to boost bladder cancer remission before surgery
Disease control OngoingThis is a multi-center, stratified and single-blinded Phase 2 trial of neoadjuvant immunotherapy in combination with the anti-GDF15 antibody visugromab (CTL-002) for the treatment of participants with MIBC set to undergo radical Cystectomy (RC)/Re-TURBT who cannot receive or refu…
Phase: PHASE2 • Sponsor: CatalYm GmbH • Aim: Disease control
Last updated Jun 27, 2026 08:03 UTC
-
New cream shows promise for severe hand eczema in chinese patients
Disease control CompletedThe primary objective of this study is to evaluate the efficacy of twice-daily applications of delgocitinib cream 20 mg/g compared with cream vehicle in the treatment of participants with moderate to severe chronic hand eczema (CHE).
Phase: PHASE3 • Sponsor: LEO Pharma • Aim: Disease control
Last updated Jun 27, 2026 07:51 UTC
-
Promising new treatment for rare liver disease shows potential in Late-Stage trial
Disease control CompletedTo Determine the Effects of Seladelpar on Normalization of Alkaline Phosphatase Levels in Subjects with Primary Biliary Cholangitis (PBC) and an Incomplete Response or Intolerance to Ursodeoxycholic Acid (UDCA). The primary objective is to evaluate the effect of seladelpar treat…
Phase: PHASE3 • Sponsor: Gilead Sciences • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New antibody drug targets Hard-to-Treat neuroendocrine cancers
Disease control Recruiting nowThis is a first-in-human, Phase 1/2, open-label, dose escalation, dose expansion and combination study designed to evaluate the safety, tolerability, pharmacokinetics, pharmacodynamics, and preliminary efficacy of Peluntamig (PT217) as a monotherapy and in combination with chemot…
Phase: PHASE1, PHASE2 • Sponsor: Phanes Therapeutics • Aim: Disease control
Last updated Jul 17, 2026 00:00 UTC
-
New combo therapy shows promise in brain cancer trial
Disease control CompletedThis is an open label study to determine the safety and preliminary evidence of a therapeutic effect of azeliragon in patients with newly diagnosed glioblastoma receiving concurrent radiation and temozolomide.
Phase: PHASE1, PHASE2 • Sponsor: Cantex Pharmaceuticals • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Could a simple blood test and PET scan replace painful bone marrow biopsies for myelofibrosis patients?
Diagnosis Recruiting nowChronic "Philadelphia-negative" myeloproliferative syndromes are chronic blood disorders. They include essential thrombocythemia, polycythemia vera, and myelofibrosis. Myelofibrosis may arise de novo ("primary myelofibrosis") or represent the evolution of essential thrombocythemi…
Phase: NA • Sponsor: Azienda Ospedaliero-Universitaria di Parma • Aim: Diagnosis
Last updated Jun 27, 2026 09:06 UTC
-
Heart repair with stem cells: a new hope for chronic heart failure?
Disease control OngoingThe purpose of this clinical study is to evaluate the feasibility, safety and efficacy of intramyocardial injection of human induce pluripotent stem cell-derived cardiomyocytes (HiCM-188) during coronary artery bypass grafting (CABG) surgery in patients with severe chronic ischem…
Phase: PHASE1, PHASE2 • Sponsor: HELP Therapeutics Co., Ltd. • Aim: Disease control
Last updated Jun 27, 2026 09:03 UTC
-
New hope for lymphoma patients: trial pits novel drugs against standard chemo
Disease control Recruiting nowThe aim of the REFRACT clinical trial is to find new therapies with improved outcomes compared to the current standard treatment available, in patients with relapsed or refractory follicular lymphoma. This will be done by comparing patients who have received a new treatment again…
Phase: PHASE2 • Sponsor: University of Birmingham • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC